Key Segments:
By Product Type
-
Stabilizers
-
Surfactants
-
Bulking Agents & Diluents
-
Buffering Agents
-
Others
By Formulation
-
Liquid/Parenteral
-
Lyophilized
By Source
-
Synthetic
-
Natural/Biological
By Application
-
Monoclonal Antibodies
-
Vaccines
-
Recombinant Proteins
-
Cell & Gene Therapies
-
Other Biologics
By End User
-
Biopharmaceutical & Biotechnology Companies
-
CDMOs/CMOs
-
Academic & Research Institutes
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company's specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key Palyers include BASF SE, Evonik Industries AG, DuPont de Nemours, Inc., Ashland Inc., and Croda International Plc, among others.
Key opportunities include expanding biologics pipelines, increasing demand for advanced injectable formulations, development of high-performance excipients, and growing adoption of innovative drug-delivery technologies.
The major growth factor is rising demand for high-concentration and subcutaneous biologic formulations, expansion of monoclonal antibody and biosimilar manufacturing capacity, and increasing adoption of novel, animal-origin-free excipient grades.
The Stabilizers segment dominated the Biologic Excipients Market by product type, representing the largest share of revenue in 2025.
North America dominated the Biologic Excipients Market in 2025, holding an estimated 43.9% share of total global market revenue.
